Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses.
Public Health Nursing
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses.
Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses. Cell Rep. 2019 10 15; 29(3):573-588.e7.
View in:
PubMed
subject areas
Animals
Dimerization
Drug Resistance, Neoplasm
Female
Gene Expression Regulation, Neoplastic
Humans
Intracellular Signaling Peptides and Proteins
Melanoma
Mice
Mice, Nude
Mitogen-Activated Protein Kinases
Oncogene Proteins, Fusion
Protein Isoforms
Protein Kinase Inhibitors
Proto-Oncogene Proteins B-raf
ras Proteins
RNA Interference
RNA, Small Interfering
Signal Transduction
authors with profiles
Kevin Michael Brown